Titre :
  • Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
Auteur : Croxford, J Ludovic ; Pryce, Gareth ; Jackson, Samuel J ; Ledent, Catherine ; Giovannoni, Gavin ; Pertwee, Roger G ; Yamamura, Takashi ; Baker, David
Informations sur la publication : Journal of neuroimmunology, 193, 1-2, (page 120-129)
Statut de publication : Publié, 2008-01
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Cannabinoids
Experimental autoimmune encephalomyelitis
Immunosuppression
Multiple sclerosis
Neuroprotection
Mots-clés MeSH : Animals
Benzoxazines -- pharmacology
Cannabinoids -- pharmacology
Cannabinoids -- therapeutic use
Encephalomyelitis, Autoimmune, Experimental -- drug therapy
Encephalomyelitis, Autoimmune, Experimental -- immunology
Immunosuppressive Agents -- pharmacology
Immunosuppressive Agents -- therapeutic use
Mice
Mice, Inbred C57BL
Morpholines -- pharmacology
Multiple Sclerosis -- drug therapy
Multiple Sclerosis -- immunology
Naphthalenes -- pharmacology
Neuroprotective Agents -- pharmacology
Neuroprotective Agents -- therapeutic use
Piperidines -- pharmacology
Pyrazoles -- pharmacology
Receptor, Cannabinoid, CB1 -- physiology
Receptor, Cannabinoid, CB2 -- physiology
T-Lymphocytes -- drug effects
T-Lymphocytes -- immunology
Note : Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0165-5728 
info:doi/10.1016/j.jneuroim.2007.10.024
info:pii/S0165-5728(07)00396-7
info:pmid/18037503